Rockledge, FLNCT06453213Now EnrollingIRB Ready

Partial-Onset Epilepsy Clinical Trial in Rockledge, FL

Access cutting-edge partial-onset epilepsy treatment through this clinical trial at a research site in Rockledge. Study-provided care at no cost to qualified participants.

Sponsored by SK Life Science, Inc.

Quick Self-Assessment

See if you qualify for this Rockledge location

Preparing your pre-screening questions...

Expert Care in Rockledge

Access partial-onset epilepsy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related partial-onset epilepsy treatment provided free

Apply for This Rockledge Location

Check if you qualify for this partial-onset epilepsy clinical trial in Rockledge, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Rockledge

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Rockledge site if eligible
  4. 4Begin participation

About This Partial-Onset Epilepsy Study in Rockledge

Cenobamate (YKP3089) is a small molecule approved in the United States (US), Europe and several other countries around the world for the treatment of Partial-Onset (focal) seizures in adult subjects (≥18 years of age). In the US it is approved for use as monotherapy, however, there is little clinical data assessing its use as monotherapy in adults with POS. This study is designed to explore the effectiveness of doses of 100 mg/day and 200 mg/day as monotherapy in adult subjects with newly diagno

Sponsor: SK Life Science, Inc.

Who Can Participate

Inclusion Criteria

Be considered reliable and willing to be available for the study period and are able to record seizures and report adverse events (AEs) himself/herself or have a caregiver who can record seizures and report AEs for them. 2. Male or female subjects 18-74 years of age with a diagnosis of partial-onset seizures (POS) according to the 2017 ILAE Classification of Epileptic Seizures. Diagnosis will be established by clinical history and an electroencephalogram (EEG) consistent with POS. Subjects with a normal EEG could be included provided they met the other diagnostic criteria according to clinical history. 3. Subjects who are newly diagnosed or have recurrent epilepsy and have experienced: 1. At least 2 unprovoked seizures (at least \>24 hours apart) within the 1 year prior to Day 1 of the Treatment Period, of which, at least 1 unprovoked seizure (but below 20 seizures) occurred in the 12 weeks prior to Day 1 of the Treatment Period. OR 2. 1 unprovoked

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Rockledge?

Yes, this clinical trial (NCT06453213) has an active research site in Rockledge, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Partial-Onset Epilepsy Treatment Options in Rockledge, FL

If you're searching for partial-onset epilepsy treatment options in Rockledge, FL, this clinical trial (NCT06453213) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Rockledge research site is actively enrolling participants for this clinical trial. You'll receive care from experienced partial-onset epilepsy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all partial-onset epilepsy clinical trials near you to find additional studies recruiting in your area.

More Epilepsy Trials in Rockledge, FL

See all epilepsy clinical trials recruiting in Rockledge — not just this study.

Browse Epilepsy Trials in Rockledge

Ready to Join in Rockledge?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Rockledge, FL